168 related articles for article (PubMed ID: 21382920)
1. Changes in platelet count as a predictive tool in sickle cell acute vaso-occlusive crises: a pediatric study.
Shanley LA; Ebeling M; Titus MO
Clin Pediatr (Phila); 2011 Jul; 50(7):657-61. PubMed ID: 21382920
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of reticulated platelets in patients with sickle cell diseases.
Noronha JF; Costa FF; Saad ST; Lorand-Metze IG; Grotto HZ
Thromb Res; 2007; 121(2):259-67. PubMed ID: 17521711
[TBL] [Abstract][Full Text] [Related]
3. Score Predicting Acute Chest Syndrome During Vaso-occlusive Crises in Adult Sickle-cell Disease Patients.
Bartolucci P; Habibi A; Khellaf M; Roudot-Thoraval F; Melica G; Lascaux AS; Moutereau S; Loric S; Wagner-Ballon O; Berkenou J; Santin A; Michel M; Renaud B; Lévy Y; Galactéros F; Godeau B
EBioMedicine; 2016 Aug; 10():305-11. PubMed ID: 27412264
[TBL] [Abstract][Full Text] [Related]
4. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A
Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
[TBL] [Abstract][Full Text] [Related]
5. Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy.
Hoppe CC; Styles L; Heath LE; Zhou C; Jakubowski JA; Winters KJ; Brown PB; Rees DC; Heeney MM
Pediatr Blood Cancer; 2016 Feb; 63(2):299-305. PubMed ID: 26402148
[TBL] [Abstract][Full Text] [Related]
6. Is morphine exposure associated with acute chest syndrome in children with vaso-occlusive crisis of sickle cell disease? A 6-year case-crossover study.
Finkelstein Y; Schechter T; Garcia-Bournissen F; Kirby M; Nurmohamed L; Juurlink DN; Blanchette V; Koren G
Clin Ther; 2007 Dec; 29(12):2738-43. PubMed ID: 18201591
[TBL] [Abstract][Full Text] [Related]
7. Types of crises in sickle cell disease patients presenting at the haematology day care unit (HDCU), University College Hospital (UCH), Ibadan.
Olabode JO; Shokunbi WA
West Afr J Med; 2006; 25(4):284-8. PubMed ID: 17402517
[TBL] [Abstract][Full Text] [Related]
8. Human platelet alloantigens (HPA) 1, HPA2, HPA3, HPA4, and HPA5 polymorphisms in sickle cell anemia patients with vaso-occlusive crisis.
Al-Subaie AM; Fawaz NA; Mahdi N; Al-Absi IK; Al-Ola K; Ameen G; Almawi WY
Eur J Haematol; 2009 Dec; 83(6):579-85. PubMed ID: 19702628
[TBL] [Abstract][Full Text] [Related]
9. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
Buchanan ID; Woodward M; Reed GW
Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170
[TBL] [Abstract][Full Text] [Related]
10. High resource hospitalizations among children with vaso-occlusive crises in sickle cell disease.
Raphael JL; Mei M; Mueller BU; Giordano T
Pediatr Blood Cancer; 2012 Apr; 58(4):584-90. PubMed ID: 21584938
[TBL] [Abstract][Full Text] [Related]
11. Orbital infarction in sickle cell disease.
Ganesh A; Al-Zuhaibi S; Pathare A; William R; Al-Senawi R; Al-Mujaini A; Hussain S; Wali Y; Alkindi S; Zachariah M; Knox-Macaulay H
Am J Ophthalmol; 2008 Oct; 146(4):595-601. PubMed ID: 18662809
[TBL] [Abstract][Full Text] [Related]
12. Epidural analgesia in the management of severe vaso-occlusive sickle cell crisis.
Yaster M; Tobin JR; Billett C; Casella JF; Dover G
Pediatrics; 1994 Feb; 93(2):310-5. PubMed ID: 8121746
[TBL] [Abstract][Full Text] [Related]
13. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
[TBL] [Abstract][Full Text] [Related]
14. Day hospital versus inpatient management of uncomplicated vaso-occlusive crises in children with sickle cell disease.
Raphael JL; Kamdar A; Wang T; Liu H; Mahoney DH; Mueller BU
Pediatr Blood Cancer; 2008 Sep; 51(3):398-401. PubMed ID: 18300322
[TBL] [Abstract][Full Text] [Related]
15. Does e-pain plan improve management of sickle cell disease associated vaso-occlusive pain crisis? a mixed methods evaluation.
Kato-Lin YC; Krishnamurti L; Padman R; Seltman HJ
Int J Med Inform; 2014 Nov; 83(11):814-24. PubMed ID: 25179666
[TBL] [Abstract][Full Text] [Related]
16. The effect of acute pain crisis on exhaled nitric oxide levels in children with sickle cell disease.
Pawar SS; Panepinto JA; Brousseau DC
Pediatr Blood Cancer; 2008 Jan; 50(1):111-3. PubMed ID: 16619223
[TBL] [Abstract][Full Text] [Related]
17. Platelet distribution width (PDW) is increased in vaso-occlusive crisis in sickle cell disease.
Amin MA; Amin AP; Kulkarni HR
Ann Hematol; 2004 Jun; 83(6):331-5. PubMed ID: 15052371
[TBL] [Abstract][Full Text] [Related]
18. Are there phases to the vaso-occlusive painful episode in sickle cell disease?
Jacob E; Beyer JE; Miaskowski C; Savedra M; Treadwell M; Styles L
J Pain Symptom Manage; 2005 Apr; 29(4):392-400. PubMed ID: 15857743
[TBL] [Abstract][Full Text] [Related]
19. Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome.
Liem RI; O'Gorman MR; Brown DL
Am J Hematol; 2004 May; 76(1):19-25. PubMed ID: 15114592
[TBL] [Abstract][Full Text] [Related]
20. Treatment of uncomplicated vaso-occlusive crises in children with sickle cell disease in a day hospital.
Raphael JL; Kamdar A; Beavers MB; Mahoney DH; Mueller BU
Pediatr Blood Cancer; 2008 Jul; 51(1):82-5. PubMed ID: 18383165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]